Join the club for FREE to access the whole archive and other member benefits.

Kristen Fortney

Chief Executive Officer and co-founder at BioAge

Kristen leads BIOAGE in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BIOAGE’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 18 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.

Visit website: https://bioagelabs.com/people/kristen.html

 kristenfortney

 kpfortney

See also: Company BIOAGE - Developing a broad pipeline of therapies to extend human healthspan and lifespan

Details last updated 23-Apr-2020

Kristen Fortney is also referenced in the following:

ARDD 2021 - 8th Aging Research and Drug Discovery Meeting

31-Aug-2021 to 03-Sep-2021

Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

BIOAGE

Developing a broad pipeline of therapies to extend human healthspan and lifespan

Global Healthspan Summit (GHS) 2025

04-Feb-2025

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Global Healthspan Summit 2023

29-Nov-2023 to 30-Nov-2023

Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)

Hacking your health

BBC Click meets biohackers and companies who believe it will be possible to live on to well beyond 100

Investing in the age of longevity

17-Nov-2022

London event organized by Master Investor bringing longevity scientists and inventors speaking about latest ageing related discoveries and investments

Longevity Leaders World Congress 2022

26-Feb-2022 to 27-Feb-2022

Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)

Kristen Fortney News

Longevity Technology speaks to BioAge's CEO about clinical trial progress

Longevity Technology speaks to BioAge's CEO about clinical trial progress

Longevity Technology - 06-Jan-2023

Had success in reducing muscle atrophy and discovered novel class of molecules to target cognitive decline

Humanity Inc app launches initially in UK - determines your rate of ageing

Humanity Inc app launches initially in UK - determines your rate of ageing

TechCrunch - 04-Aug-2021

Produces personalised tips by comparing phone/wearables data with UK Biobank

Launching the next wave of longevity biotech startups

Launching the next wave of longevity biotech startups

Longevity Technology - 29-Jun-2021

Connecting aspiring longevity founders with mentors to drive innovation in anti-ageing biotech

Bioage licenses new drugs to treat ageing and age-related diseases

Bioage licenses new drugs to treat ageing and age-related diseases

Lifespan.io (LEAF) - 28-Apr-2021

Raised $90M in series C funding - off to a great start initiating three clinical trials

BioAge's anti-ageing drug to treat Covid-19 enters phase 2 trial

BioAge's anti-ageing drug to treat Covid-19 enters phase 2 trial

Longevity Technology - 22-Mar-2021

Reverses immune ageing and can prevent death from coronavirus infection in the elderly

Bioage's lead therapies moved closer to the clinic

Bioage's lead therapies moved closer to the clinic

Longevity Technology - 03-Dec-2020

Lead therapies of BioAge to treat age related diseases enter phase 2 trials